Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Prepaid Assets (2016 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Prepaid Assets for 13 consecutive years, with $34.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Prepaid Assets rose 73.98% year-over-year to $34.6 million, compared with a TTM value of $34.6 million through Sep 2025, up 73.98%, and an annual FY2024 reading of $22.0 million, up 32.44% over the prior year.
  • Prepaid Assets was $34.6 million for Q3 2025 at Tandem Diabetes Care, up from $28.4 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $34.6 million in Q3 2025 and bottomed at $6.1 million in Q2 2021.
  • Average Prepaid Assets over 5 years is $15.5 million, with a median of $15.4 million recorded in 2023.
  • The sharpest move saw Prepaid Assets decreased 14.13% in 2022, then soared 129.04% in 2023.
  • Year by year, Prepaid Assets stood at $8.4 million in 2021, then dropped by 14.13% to $7.2 million in 2022, then skyrocketed by 129.04% to $16.6 million in 2023, then skyrocketed by 32.44% to $22.0 million in 2024, then soared by 57.56% to $34.6 million in 2025.
  • Business Quant data shows Prepaid Assets for TNDM at $34.6 million in Q3 2025, $28.4 million in Q2 2025, and $27.1 million in Q1 2025.